NCCN 2014 Congress Series™: Melanoma

La Jolla, CA US
June 21, 2014

This congress is an educational program that addresses health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with melanoma and related skin cancers, management of both early-stage and late-stage diseases and advanced cancer.

View agenda

View fees

 

Target Audience

This educational program is designed to meet the educational needs of oncologists, nurses, pharmacists, dermatologists, and other healthcare professionals who manage patients with melanoma and related skin cancers.

Learning Objectives

Following this activity, participants should be able to: 

  • Identify tumor characteristics that should be included in the pathology report at initial melanoma diagnosis
  • Explain the importance of mitotic rate as part of the pathologic evaluation of melanoma lesions
  • Summarize the local treatment options for patients with stage III melanoma
  • Compare the benefits and concerns surrounding adjuvant radiation therapy in stage III melanoma
  • Explain the difference between immunotherapy and targeted therapy as it relates to  advanced melanoma
  • Describe the unique toxicity profiles and surveillance necessary for recently-approved agents in targeting advanced melanoma
Additional information
Supporters: 

Supported by educational grants from:

  • Bristol-Myers Squibb
  • Genentech
  • Merck Sharp & Dohme Corp.
Course summary
Available credit: 
  • 2.50 Participation
  • 2.50 Nurse
  • 2.50 Pharmacist
  • 2.50 Physician
Course opens: 
06/19/2014
Course expires: 
11/07/2014
Event starts: 
06/21/2014 - 8:45am EDT
Event ends: 
06/21/2014 - 11:55pm EDT
Cost:
$0.00
Add to calendar: 
Goldberg Auditorium
3855 Health Sciences Drive
UC San Diego Moores Cancer Center
La Jolla, CA 92093
United States

Daniel G. Coit, MD
Memorial Sloan Kettering Cancer Center

Gregory A. Daniels, MD, PhD
UC San Diego Moores Cancer Center

Dominick DiMaio, MD
Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center

 

This activity is approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are also provided. View complete accreditation information

Available Credit

  • 2.50 Participation
  • 2.50 Nurse
  • 2.50 Pharmacist
  • 2.50 Physician

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection
  • Adobe Reader or other PDF reader software for certificate viewing/printing